Papers
4
Total Citations
111
H-Index
3
About
No biography available yet.
Research Focus
Medicine4 · 111 citations
Surgery4 · 111 citations
Internal medicine4 · 111 citations
Cancer4 · 111 citations
Chemotherapy2 · 64 citations
Cisplatin1 · 62 citations
Immunotherapy1 · 62 citations
Neoadjuvant therapy1 · 62 citations
Esophageal squamous cell carcinoma1 · 62 citations
Carcinoma1 · 62 citations
Breast cancer1 · 62 citations
Oncology1 · 62 citations
Key Achievements
3
H-Index
4
Papers
111
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)
62 citations · 2022
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Tianjin Medical University Cancer Institute and Hospital
Top Papers
- 1
- 2
- 3
- 4
Key Collaborators
JYJie Yue4 shared papersHJHongjing Jiang4 shared papersXSXiaobin Shang4 shared papersXDXiaofeng Duan4 shared papersZMZhao Ma3 shared papersLGLei Gong2 shared papersCZChen Zhang2 shared papersXRXiubao Ren1 shared papersRLRunmei Li1 shared papersZYZhentao Yu1 shared papersLLLiang Liu1 shared papersGZGang Zhao1 shared papersBMBin Meng1 shared papersZMZhao Ma1 shared papersPTPeng Tang1 shared papersZYZhentao Yu1 shared papersWZWei‐Hong Zhang1 shared papersZCZuoyu Chen1 shared papersFLFei Liang1 shared papers
Not generated yet